Centre for Biophotonics, Lancaster Environment Centre, Lancaster University, Lancaster LA1 4YQ, UK.
Analyst. 2013 Jul 21;138(14):3917-26. doi: 10.1039/c3an36654e. Epub 2013 Jan 17.
Currently available screening tests do not deliver the required sensitivity and specificity for accurate diagnosis of ovarian or endometrial cancer. Infrared (IR) spectroscopy of blood plasma or serum is a rapid, versatile, and relatively non-invasive approach which could characterize biomolecular alterations due to cancer and has potential to be utilized as a screening or diagnostic tool. In the past, no such approach has been investigated for its applicability in screening and/or diagnosis of gynaecological cancers. We set out to determine whether attenuated total reflection Fourier-transform IR (ATR-FTIR) spectroscopy coupled with a proposed classification machine could be applied to IR spectra obtained from plasma and serum for accurate class prediction (cancer vs. normal). Plasma and serum samples were obtained from ovarian cancer cases (n = 30), endometrial cancer cases (n = 30) and non-cancer controls (n = 30), and subjected to ATR-FTIR spectroscopy. Four derived datasets were processed to estimate the real-world diagnosis of ovarian and endometrial cancer. Classification results for ovarian cancer were remarkable (up to 96.7%), whereas endometrial cancer was classified with a relatively high accuracy (up to 81.7%). The results from different combinations of feature extraction and classification methods, and also classifier ensembles, were compared. No single classification system performed best for all different datasets. This demonstrates the need for a framework that can accommodate a diverse set of analytical methods in order to be adaptable to different datasets. This pilot study suggests that ATR-FTIR spectroscopy of blood is a robust tool for accurate diagnosis, and carries the potential to be utilized as a screening test for ovarian cancer in primary care settings. The proposed classification machine is a powerful tool which could be applied to classify the vibrational spectroscopy data of different biological systems (e.g., tissue, urine, saliva), with their potential application in clinical practice.
目前的筛查测试无法提供准确诊断卵巢癌或子宫内膜癌所需的灵敏度和特异性。血浆或血清的红外(IR)光谱是一种快速、多功能且相对非侵入性的方法,可以描述由于癌症引起的生物分子变化,并有潜力用作筛查或诊断工具。过去,尚未研究过这种方法在妇科癌症筛查和/或诊断中的适用性。我们着手确定衰减全反射傅里叶变换红外(ATR-FTIR)光谱是否可以与拟议的分类机器结合应用于从血浆和血清中获得的 IR 光谱,以进行准确的分类预测(癌症与正常)。从卵巢癌病例(n = 30)、子宫内膜癌病例(n = 30)和非癌症对照(n = 30)中获取血浆和血清样本,并进行 ATR-FTIR 光谱分析。处理了四个衍生数据集以估计卵巢和子宫内膜癌的实际诊断。卵巢癌的分类结果非常显著(高达 96.7%),而子宫内膜癌的分类准确性相对较高(高达 81.7%)。比较了不同特征提取和分类方法以及分类器集合的组合的分类结果。没有任何单一的分类系统在所有不同的数据集上表现最好。这表明需要一个能够适应不同分析方法的框架,以便能够适应不同的数据集。这项初步研究表明,血液 ATR-FTIR 光谱是一种准确诊断的强大工具,有可能在初级保健环境中用作卵巢癌的筛查测试。拟议的分类机器是一种强大的工具,可用于对不同生物系统(例如组织、尿液、唾液)的振动光谱数据进行分类,其在临床实践中具有潜在的应用价值。